The ability of KCNQ channel activators to prevent the development of tinnitus is probably occurring through the reversal of the pathogenic reduction of KCNQ2/3 channel activity and the promotion of the natural resilience to tinnitus. The gene discussed is KCNQ2; the disease is Tinnitus.